SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jef saunders who wrote (120)3/14/2000 8:41:00 PM
From: Orwell  Read Replies (1) of 127
 
This is a gift horse buying opportunity for ADRX of emense proportion (also AVII, ADRM, EPIX, MEDX, NEOT).

Comments today by Clinton are bad for genomics hunters, but good for drug companies and drug discovery companies because these companies can now cash in on the genomic information for free to develop drugs that will then be for profit.

I.E. Clinton only wishes to give the building blocks to the med community, after that it is every man for himself to find a useful way to apply the information towards therapies. Sort of like Science vs Engineering which is applied pure science towards something useful.

<EOM>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News